Novozymes
kr 413.00Change from previous close: −1.55%Absolute change: −kr 6.50
At a glance
- Revenue growth
- +8.45%
- 2025 vs 2024
- Net income growth
- +90.84%
- 2025 vs 2024
- Net margin
- 14.0%
- 2024: 8.0%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 16,349 | 15,196 | 3,809 | 3,762 | 3,331 |
| Current assets | 1,983 | 1,879 | 1,270 | 1,242 | 1,052 |
| Cash and equivalents | 275 | 280 | 150 | 140 | 130 |
| Short-term investments | 20.3 | 4.0 | 5.4 | 10.7 | — |
| Receivables | 915 | 863 | 583 | 557 | 510 |
| Inventory | 772 | 721 | 487 | 511 | 402 |
| Net property, plant and equipment | 2,998 | 2,968 | 1,654 | 1,623 | 1,370 |
| Goodwill | 6,193 | 5,605 | 265 | 270 | 272 |
| Other intangible assets | 4,896 | 4,419 | 343 | 362 | 404 |
| Long-term investments | 17.5 | 24.0 | 27.5 | 30.0 | 3.9 |
| Current liabilities | 2,741 | 1,088 | 973 | 936 | 763 |
| Accounts payable | 421 | 423 | 217 | 251 | 200 |
| Long-term debt | 1,145 | 1,366 | 612 | 487 | 495 |
| Total debt | — | 1,797 | 1,039 | 919 | 832 |
| Total liabilities | 5,494 | 4,020 | 1,884 | 1,849 | 1,689 |
| Total equity (incl. minority) | 10,855 | 11,176 | 1,926 | 1,913 | 1,642 |
| Retained earnings | 11,159 | 11,032 | 1,846 | 1,756 | 1,520 |
| Minority interest | 0.0 | 0.0 | 50.0 | 52.6 | 51.0 |